IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1126-1136 out of 1136.

<< < 41 | 42 | 43 | 44 | 45 | 46

Public Release: 4-Jun-2012
Nature Cell Biology
Clarification of unique communication channel with possible role in tumor
Guido David, associated with VIB and KU Leuven, and Pascale Zimmermann have discovered a new mechanism for the formation of exosomes, small vesicles with a role in tumor development. This research has been published in the authoritative journal Nature Cell Biology.

Contact: Sooike Stoops
sooike.stoops@vib.be
32-474-289-252
VIB (the Flanders Institute for Biotechnology)

Public Release: 4-Jun-2012
Annals of Internal Medicine
Embargoed news from Annals of Internal Medicine
Below is information about three articles being published in the June 5 issue of Annals of Internal Medicine. The information is not intended to substitute for the full articles as sources of information. Annals of Internal Medicine attribution is required for all coverage.

Contact: Abbey Anderson
aanderson@acponline.org
215-351-2656
American College of Physicians

Public Release: 4-Jun-2012
Archives of General Psychiatry
Early childhood neglect may raise risk of adult skin cancer
Skin cancer patients whose childhood included periods of neglect or maltreatment are at a much greater risk for their cancers to return when they face a major stressful event, based on a new study.
NIH/National Cancer Institute, American Cancer Society

Contact: Christopher Fagundes
Fagundes.1@osu.edu
614-366-3642
Ohio State University

Public Release: 4-Jun-2012
2012 American Society of Clinical Oncology Annual Meeting
Antidepressant helps relieve pain from chemotherapy, study finds
The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful tingling feelings caused by chemotherapy in 59 percent of patients, a new study finds. This is the first clinical trial to find an effective treatment for this pain.
NIH/National Cancer Institute, Lilly Pharmaceuticals

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 4-Jun-2012
2012 American Society of Clinical Oncology Annual Meeting
Ginseng fights fatigue in cancer patients, Mayo Clinic-led study finds
High doses of the herb American ginseng (Panax quinquefolius) over two months reduced cancer-related fatigue in patients more effectively than a placebo, a Mayo Clinic-led study found.
NIH/National Cancer Institute, Breast Cancer Research Foundation

Contact: Joe Dangor
newsbureau@mayo.edu
507-284-5005
Mayo Clinic

Public Release: 4-Jun-2012
2012 American Society of Clinical Oncology Annual Meeting
Childhood cancer treatment found to pose similar risk for breast cancer as BRCA mutations
New data reveals that women treated with radiation to the chest for childhood cancer have a high risk of developing breast cancer similar to that of women with BRCA1/2 mutations.
NIH/National Cancer Institute

Contact: Andrea Molinatti
molinata@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center

Public Release: 4-Jun-2012
2012 American Society of Clinical Oncology Annual Meeting
Blood
Drug combination highly effective for newly diagnosed myeloma patients
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses- the best reported to date.
Multiple Myeloma Research Consortium, Onyx Pharmaceuticals Inc., Celgene Corp., University of Michigan

Contact: John Easton
john.easton@uchospitals.edu
773-795-5225
University of Chicago Medical Center

Public Release: 3-Jun-2012
2012 American Society of Clinical Oncology Annual Meeting
Journal of Clinical Oncology
Intermittent hormone therapy for prostate cancer inferior to continuous therapy
An international randomized study finds intermittent androgen-deprivation therapy has some quality-of-life benefits, but overall survival times don't measure up to those seen with continuous therapy.
NIH/National Cancer Institute

Contact: Frank DeSanto
fdesanto@umich.edu
734-998-0114
University of Michigan Health System

Public Release: 3-Jun-2012
2012 American Society of Clinical Oncology Annual Meeting
Journal of Clinical Oncology
Lower income cancer patients less likely to be involved in clinical trials
A large SWOG survey finds patients with lower income less likely to participate in a clinical trial and more likely to be concerned about how to pay for clinical trial participation.
NIH/National Cancer Institute

Contact: Frank DeSanto
fdesanto@umich.edu
734-998-0114
University of Michigan Health System

Public Release: 3-Jun-2012
2012 American Society of Clinical Oncology Annual Meeting
New breast cancer drug halts tumor growth better than standard therapy
A new cancer treatment that links chemotherapy with an agent that homes in on specific breast cancer cells was significantly better than the current drug regimen at keeping patients' advanced tumors from progressing, according to results from a phase III clinical trial led by Kimberly Blackwell, M.D., of the Duke Cancer Institute.

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 3-Jun-2012
Lower income patients less likely to participate in cancer clinical trials
Lower-income cancer patients are less likely to participate in cancer clinical trials, according to a study presented at the American Society of Clinical Oncology 2012 meeting.
NIH/National Cancer Institute

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System

Showing releases 1126-1136 out of 1136.

<< < 41 | 42 | 43 | 44 | 45 | 46

  Search News Releases

     

 

 

EurekAlert!